Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.27 USD | +3.33% | +0.96% | -37.49% |
May. 16 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Apr. 08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
Financials (USD)
Sales 2025 * | - | Sales 2026 * | 21.49M | Capitalization | 324M |
---|---|---|---|---|---|
Net income 2025 * | -229M | Net income 2026 * | -231M | EV / Sales 2025 * | - |
Net cash position 2025 * | 144M | Net cash position 2026 * | 167M | EV / Sales 2026 * | 7.29 x |
P/E ratio 2025 * |
-1.57
x | P/E ratio 2026 * |
-1.96
x | Employees | 331 |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 94.34% |
Latest transcript on Replimune Group, Inc.
1 day | +3.33% | ||
1 week | +0.96% | ||
1 month | -17.01% | ||
3 months | -38.58% | ||
6 months | -52.86% | ||
Current year | -37.49% |
Managers | Title | Age | Since |
---|---|---|---|
Sushil Patel
CEO | Chief Executive Officer | 52 | 21-05-02 |
Founder | 51 | 15-02-28 | |
Robert Coffin
FOU | Founder | 58 | 15-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paolo Pucci
BRD | Director/Board Member | 63 | 20-03-31 |
Joseph Slattery
BRD | Director/Board Member | 59 | 17-09-30 |
Robert Coffin
FOU | Founder | 58 | 15-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.03% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 5.27 | +3.33% | 794,099 |
24-05-30 | 5.1 | +1.80% | 1,113,513 |
24-05-29 | 5.01 | -3.28% | 1,244,285 |
24-05-28 | 5.18 | -0.77% | 910,583 |
24-05-24 | 5.22 | -7.77% | 514,215 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.49% | 324M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- REPL Stock